Sotorasib Shows Benefit in Certain Pancreatic Cancers Sotorasib Shows Benefit in Certain Pancreatic Cancers

Sotorasib, approved for lung cancer, has demonstrated clinically meaningful anticancer activity and tolerability in patients with heavily pretreated KRASG12C-mutated advanced pancreatic cancer.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news